Hans Wandall, MD. Ph.D.

Scientific Co-Founder

Hans Wandall - GOTHans Wandall is the co-director of the center for glycobiology at the University of Copenhagen.

Wandall’s research is on the forefront of genetic dissection of glycan functions, establishing epithelial tissue models that can be used to dissect specific glycan functions in cancer and viral infection.

Wandall’s work on cancer models focuses on glycan biomarker discovery developing glycopeptide array and identification of autoantibody signatures with diagnostic value and developing a genetic approach to functional glycomics.

Wandall has 90 peer reviewed articles including PNAS, Nature Medicine, 
Nature Biotech, Nature Immunology, Nature Protocols, Nature Methods, PNAS, Blood, Cancer Research